Spore formation and toxin production in Clostridium difficile biofilms

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Semenyuk, Ekaterina G ^a   Laning, Michelle L ^a   Foley, Jennifer ^a   Johnston, Pehga F ^a   Knight, Katherine L ^a   Gerding, Dale N ^b   Driks, Adam ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CLOSTRIDIUM TOXIN; DNA; EXTRACELLULAR DNA; METRONIDAZOLE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL SPORE; BACTERIAL STRAIN; BIOFILM; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; NONHUMAN; SPORE GERMINATION; SPOROGENESIS; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIAL TOXINS; BIOFILMS; CLOSTRIDIUM DIFFICILE; DNA, BACTERIAL; GERMINATION; POLYSACCHARIDES; PROTEINS; SPORES, BACTERIAL;

EID: 84899666921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087757     Document Type: Article

References (63)

1. Kostakioti M, Hadjifrangiskou M, Hultgren SJ (2013) Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med 3(4).
2. Stoodley P, Sauer K, Davies DG, Costerton JW (2002) Biofilms as complex differentiated communities. Annu Rev Microbiol 56: 187-209. (Pubitemid 35217453)
3. Vlamakis H, Chai Y, Beauregard P, Losick R, Kolter R (2013) Sticking together: building a biofilm the Bacillus subtilis way. Nat Rev Microbiol 11: 157-168.
4. Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2: 95-108. (Pubitemid 39490064)
5. Ejrnaes K, Stegger M, Reisner A, Ferry S, Monsen T, et al. (2011) Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation. Virulence 2: 528-537.
6. Daniel M, Imtiaz-Umer S, Fergie N, Birchall JP, Bayston R (2012) Bacterial involvement in otitis media with effusion. Int J Pediatr Otorhinolaryngol 76: 1416-1422.
7. Rybtke MT, Jensen PO, Hoiby N, Givskov M, Tolker-Nielsen T, et al. (2011) The implication of Pseudomonas aeruginosa biofilms in infections. Inflamm Allergy Drug Targets 10: 141-157.
8. Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193. (Pubitemid 34303762)
9. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35: 322-332.
10. Roland PS (2002) Chronic suppurative otitis media: a clinical overview. Ear Nose Throat J 81: 8-10.
11. Voth DE, Ballard JD (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18: 247-263. (Pubitemid 40548293)
12. Hookman P, Barkin JS (2009) Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 15: 1554-1580.
13. McDonald LC, Lessa F, Sievert D, Wise M, Herrera R, et al. (2012) Vital signs: Preventing Clostridium difficile infections. MMWR 61: 157-162.
14. Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7: 526-536.
15. Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, et al. (2012) Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 80: 62-73.
16. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, et al. (2008) Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 197: 435-438. (Pubitemid 351263426)
17. Carter GP, Rood JI, Lyras D (2010) The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. Gut Microbes 1: 58-64.
18. O'Connor JR, Johnson S, Gerding DN (2009) Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136: 1913-1924.
19. Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan VK, et al. (2010) Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol 192: 4904-4911.
20. Vohra P, Poxton IR (2011) Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiology 157: 1343-1353.
21. Burns DA, Heeg D, Cartman ST, Minton NP (2011) Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027. PLoS One 6: e24894.
22. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, et al. (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364: 422-431.
23. Pepin J, Routhier S, Gagnon S, Brazeau I (2006) Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 42: 758-764. (Pubitemid 43363928)
24. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, et al. (2013) Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection. Clin Infect Dis 56: 1589-1600.
25. Petrella LA, Sambol SP, Cheknis A, Nagaro K, Kean Y, et al. (2012) Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 55: 351-357.
26. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, et al. (2012) Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8: e1002995.
27. Buckley AM, Spencer J, Candlish D, Irvine JJ, Douce GR (2011) Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291. J Med Microbiol 60: 1174-1180.
28. Branda SS, Gonzalez-Pastor JE, Ben-Yehuda S, Losick R, Kolter R (2001) Fruiting body formation by Bacillus subtilis. Proc Natl Acad Sci U S A 98: 11621-11626. (Pubitemid 32928778)
29. Wang ZW, Lee SH, Elkins JG, Morrell-Falvey JL (2011) Spatial and temporal dynamics of cellulose degradation and biofilm formation by Caldicellulosiruptor obsidiansis and Clostridium thermocellum. AMB Express 1: 30.
30. Napoli F, Olivieri G, Russo ME, Marzocchella A, Salatino P (2010) Butanol production by Clostridium acetobutylicum in a continuous packed bed reactor. J Ind Microbiol Biotechnol 37: 603-608.
31. Varga JJ, Therit B, Melville SB (2008) Type IV pili and the CcpA protein are needed for maximal biofilm formation by the gram-positive anaerobic pathogen Clostridium perfringens. Infect Immun 76: 4944-4951.
32. Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW (2012) Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. PLoS One: e50527.
33. Ethapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, et al. (2013) Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol 195: 545-555.
34. Donelli G, Vuotto C, Cardines R, Mastrantonio P (2012) Biofilm-growing intestinal anaerobic bacteria. FEMS Immunol Med Microbiol 65: 318-325.
35. Razaq N, Sambol S, Nagaro K, Zukowski W, Cheknis A, et al. (2007) Infection of hamsters with historical and epidemic BI types of Clostridium difficile. J Infect Dis 196: 1813-1819. (Pubitemid 351411942)
36. Sambol SP, Tang JK, Merrigan MM, Johnson S, Gerding DN (2001) Infection of hamsters with epidemiologically important strains of Clostridium difficile. J Infect Dis 183: 1760-1766. (Pubitemid 32523238)
37. Margolis P (1993) Establishment of cell type during sporulation in Bacillus subtilis [Ph.D.]: Harvard University.
38. Steinberger RE, Holden PA (2004) Macromolecular composition of unsaturated Pseudomonas aeruginosa biofilms with time and carbon source Biofilms. Biofilms 1: 37-47.
39. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
40. Wright A, Wait R, Begum S, Crossett B, Nagy J, et al. (2005) Proteomic analysis of cell surface proteins from Clostridium difficile. Proteomics 5: 2443-2452. (Pubitemid 40835415)
41. Reed RW, Reed GB (1948) "Drop plate" method of counting viable bacteria. Can J Res 26: 317-326.
42. George WL, Sutter VL, Citron D, Finegold SM (1979) Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 9: 214-219. (Pubitemid 9123787)
43. Johnson PF, Gerding DN, Knight KL (in press) Protection from Clostridium difficile infection in CD4 T cell and polymeric immunoglobulin receptor deficient mice. Infect Immun.
44. Merritt JH, Kadouri DE, O'Toole GA (2011) Growing and Analyzing Static Biofilms. 22:1B.1.1-1B.1.18.2; Lee K, Costerton JW, Ravel J, Auerbach RK, Wagner DM et al., editors. Antioch: John Wiley & Sons, Inc.
45. Lee K, Costerton JW, Ravel J, Auerbach RK, Wagner DM, et al. (2007) Phenotypic and functional characterization of Bacillus anthracis biofilms. Microbiology 153: 1693-1701. (Pubitemid 46952501)
46. Joseph SW, Teicher E, Carr LE, Tall B, Weiner RM (2003) Calcofluor as a fluorescent probe to detect biofilms of foodborne pathogens. J Food Safety 23.
47. Cutting SM, Vander Horn PB (1990) Molecular Biological Methods for Bacillus; Harwood CR, Cutting SM, editors. Chichester, United Kingdom: John Wiley & Sons Ltd. 27-74 p.
48. Lawley TD, Croucher NJ, Yu L, Clare S, Sebaihia M, et al. (2009) Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores. J Bacteriol 191: 5377-5386.
49. Warth AD, Ohye DF, Murrell WG (1963) The composition and structure of bacterial spores. J Cell Biol 16: 579-592.
50. Escobar-Cortes K, Barra-Carrasco J, Paredes-Sabja D (2013) Proteases and sonication specifically remove the exosporium layer of spores of Clostridium difficile strain 630. J Microbiol Methods 93: 25-31.
51. Giorno R, Bozue J, Cote C, Wenzel T, Moody K-S, et al. (2007) Morphogenesis of the Bacillus anthracis spore. J Bacteriol 189: 691-705. (Pubitemid 46183844)
52. McKenney PT, Driks A, Eskandarian HA, Grabowski P, Guberman J, et al. (2010) A distance-weighted interaction map reveals a previously uncharacterized layer of the B. subtilis spore coat. Current Biology 29: 934-938.
53. Joshi LT, Phillips DS, Williams CF, Alyousef A, Baillie L (2012) Contribution of spores to the ability of Clostridium difficile to adhere to surfaces. Appl Environ Microbiol 78: 7671-7679.
54. Steichen CT, Kearney JF, Turnbough CL, Jr. (2007) Non-uniform assembly of the Bacillus anthracis exosporium and a bottle cap model for spore germination and outgrowth. Mol Microbiol 64: 359-367. (Pubitemid 46632618)
55. DesRosier JP, Lara JC (1981) Isolation and properties of pili from spores of Bacillus cereus. J Bacteriol 145: 613-619. (Pubitemid 11140344)
56. Flemming HC, Wingender J (2010) The biofilm matrix. Nat Rev Microbiol 8: 623-633.
57. Levett PN (1991) Time-dependent killing of Clostridium difficile by metronidazole and vancomycin. J Antimicrob Chemother 27: 55-62.
58. Webb JS, Thompson LS, James S, Charlton T, Tolker-Nielsen T, et al. (2003) Cell death in Pseudomonas aeruginosa biofilm development. J Bacteriol 185: 4585-4592. (Pubitemid 36890507)
59. Lopez D, Vlamakis H, Kolter R (2009) Generation of multiple cell types in Bacillus subtilis. FEMS Microbiol Rev 33: 152-163.
60. Earl AM, Losick R, Kolter R (2007) Bacillus subtilis genome diversity. J Bacteriol 189: 1163-1170. (Pubitemid 46183894)
61. Traag BA, Driks A, Stragier P, Bitter W, Broussard G, et al. (2010) Do Mycobacteria Produce Endospores? Proc Natl Acad Sci USA 107: 878-881.
62. Williams DD, Turnbough CL, Jr. (2004) Surface layer protein EA1 is not a component of Bacillus anthracis spores but is a persistent contaminant in spore preparations. J Bacteriol 186: 566-569. (Pubitemid 38076446)
63. Wilcox MH, Spencer RC (1992) Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect 22: 85-92.